在当前的COVID-19变体中探索B细胞表位保护和抗原性转变:分析治疗用途的尖峰-抗体相互作用
Alankar Roy1, Ishani Paul1, Tanwi Paul1
1Amity Institute of Biotechnology, Amity University, Kolkata, India.
Biochemical and biophysical research communications
|November 12, 2024
概括
SARS-CoV-2 变种显示了尖端蛋白突变的融合进化,影响了传播能力和免疫逃避. 特定的抗体显示出广泛的中和能力来对抗这些不断演变的菌株.
科学领域:
- 病毒学和免疫学 病毒学和免疫学
- 结构生物学 结构生物学
- 基因组学就是基因组学.
背景情况:
- 负责COVID-19大流行的SARS-CoV-2病毒不断演变,产生具有改变特征的变种.
- 了解这些遗传变化,特别是尖端蛋白的突变,对于公共卫生和治疗开发至关重要.
研究的目的:
- 分析SARS-CoV-2感兴趣的变体 (VOI) 和正在监测中的变体 (VUM) 的表位变异.
- 评估突变对病毒抗原性和结构动态的影响.
- 评估针对不同SARS-CoV-2变体的特定抗体的中和效果.
主要方法:
- 世界卫生组织指定的VOI和VUM的评估.
- 符合性表位图和抗原性转移分析.
- 结构分析包括溶剂可访问的表面积和旋转半径.
- 抗体结合测试以评估中和潜力.
主要成果:
- 在尖蛋白抗原位点观察到的突变 (G446S,K417N,T478K,E484A,N501Y,Y505H) 的融合演变.
- 在VUMs BA.2.86和XBB.2.3.3中注意到显著的抗原性变化和表位动态.
- VOI XBB.1.5,BA.2.86和CH.1.1显示结构扩张,而EG.5.1显示最小的变化.
- 抗体CC12.1,P4A1,CV07-250,P5A-2G9和MW05在所有变体中都表现出广泛的中和活性.
结论:
- 在SARS-CoV-2变体中,表层变异是由融合进化驱动的,影响免疫逃避.
- 特定的抗体,特别是P4A1和MW05,对关键变体表现出强大的中和作用.
- 这些发现为开发针对性干预措施的发展提供了洞察力,以对抗不断演变的SARS-CoV-2菌株.
相关概念视频
Cross-reactivity
31.0K
Overview
31.0K
Conjugated Proteins
18.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K
Affinity and Avidity
35.8K
Overview
35.8K
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Antigens Involved in Adaptive Immunity
460
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
460


